Furthermore, it has recently been shown that genetic defects in the toll-like receptor (TLR)-3 and -7 dependent type I interferon (IFN) pathway as well as IFN autoantibodies are highly enriched among patients with life-threatening COVID-19 [3–5]. The gene discussed is IFNA1; the disease is COVID-19.